U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer has been featured on Patrick Timpone’s One Radio Network. Playback of the interview is available here.
January 15, 2019
· 3 min read